What is the recommended treatment regimen for an adult with low vitamin D (25‑hydroxyvitamin D) levels?

Treatment of Low Vitamin D in Adults

For adults with documented vitamin D deficiency (25-hydroxyvitamin D <30 ng/mL), initiate treatment with 50,000 IU of vitamin D2 (ergocalciferol) weekly for 8 weeks, followed by maintenance therapy of 800-2,000 IU daily. 1

Treatment Algorithm Based on 25(OH)D Levels

Step 1: Measure Baseline 25(OH)D Level

• Target level for optimal health: ≥30 ng/mL (75 nmol/L) 1, 2
• Levels of 30-80 ng/mL are considered safe and optimal 1
• Safety limit is 100 ng/mL, though no additional benefits occur above 50 ng/mL 1

Step 2: Correction Phase (If Deficient)

For 25(OH)D <30 ng/mL:

• Standard regimen: 50,000 IU vitamin D2 weekly for 8 weeks 1, 2, 3
• This provides a cumulative correcting dose of 400,000 IU over 2 months 1
• Alternative for severe deficiency (<5 ng/mL): 50,000 IU weekly for 12 weeks, then monthly 4

For 25(OH)D 20-30 ng/mL (mild insufficiency):

• Alternative approach: Add 1,000 IU daily to current intake and recheck in 3 months 2

Rule of thumb: Each 1,000 IU daily increases 25(OH)D by approximately 10 ng/mL, though individual responses vary 1

Step 3: Maintenance Phase

After correction, maintain with 800-2,000 IU daily (or weekly/monthly equivalent) 1, 2, 3

• For adults ≥50 years: 800-1,000 IU daily minimum 2
• For younger adults: 400-800 IU daily 4
• Higher doses (up to 4,000 IU daily) are safe and may be needed for certain individuals 1, 5

Step 4: Monitoring

• Recheck 25(OH)D after at least 3 months of supplementation 1
• For daily dosing: measure after 3 months to allow plateau 1
• For intermittent dosing: measure just before next dose 1
• If levels remain insufficient, increase maintenance dose and monitor compliance 1

Formulation Preferences

Vitamin D3 (cholecalciferol) is preferred over D2 (ergocalciferol) for intermittent dosing because it maintains serum levels longer 1, 2

• For daily dosing, D2 and D3 have similar efficacy 1
• D3 avoids assay specificity problems 1
• D2 is acceptable for vegetarians or those with religious preferences 1

Dosing Schedule Options

Daily dosing is preferred over large intermittent boluses 1

• Daily, weekly, or monthly regimens are acceptable 1
• Avoid single annual high doses (e.g., 500,000 IU) due to adverse outcomes 1
• Equivalent intermittent dosing: 100,000 IU every 3 months equals approximately 800 IU daily 1

Special Populations Requiring Empiric Supplementation

These groups should receive 800 IU daily without baseline testing: 1

• Dark-skinned or veiled individuals with minimal sun exposure 1
• Adults ≥65 years without major health problems 1
• Institutionalized individuals 1

Important Caveats

Malabsorption syndromes require higher doses and closer monitoring 1

• Conditions like celiac disease may need doses exceeding standard recommendations 1
• Nephrotic syndrome causes urinary losses of 25(OH)D and requires higher supplementation 4

Safety considerations:

• Doses up to 10,000 IU daily for several months show no adverse events 1
• Hypercalcemia only occurs with daily intake >100,000 IU or 25(OH)D >100 ng/mL 1
• Monitor calcium levels only in patients with primary hyperparathyroidism or granulomatous diseases 5

Do not use calcitriol or other activated vitamin D analogs to treat nutritional vitamin D deficiency 4—these are reserved for specific conditions like advanced chronic kidney disease.

Calcium supplementation (1,000-1,200 mg daily) should be added if dietary intake is inadequate 1, 2, but this depends on individual diet assessment rather than routine co-administration.